These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35778257)

  • 1. A novel homozygous frameshift mutation in the APOA1 gene associated with marked high-density lipoprotein deficiency.
    Takeda T; Ide T; Okuda D; Kuroda M; Asada S; Kirinashizawa M; Yamamoto M; Miyoshi J; Yokote K; Mizutani N
    J Clin Lipidol; 2022; 16(4):423-433. PubMed ID: 35778257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Classical LCAT deficiency resulting from a novel homozygous dinucleotide deletion in exon 4 of the human lecithin: cholesterol acyltransferase gene causing a frameshift and stop codon at residue 144.
    Teh EM; Chisholm JW; Dolphin PJ; Pouliquen Y; Savoldelli M; de Gennes JL; Benlian P
    Atherosclerosis; 1999 Sep; 146(1):141-51. PubMed ID: 10487497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A kindred with fish eye disease, corneal opacities, marked high-density lipoprotein deficiency, and statin therapy.
    Dimick SM; Sallee B; Asztalos BF; Pritchard PH; Frohlich J; Schaefer EJ
    J Clin Lipidol; 2014; 8(2):223-30. PubMed ID: 24636183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease.
    Ikewaki K; Matsunaga A; Han H; Watanabe H; Endo A; Tohyama J; Kuno M; Mogi J; Sugimoto K; Tada N; Sasaki J; Mochizuki S
    Atherosclerosis; 2004 Jan; 172(1):39-45. PubMed ID: 14709355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and functional analysis of missense mutations in the lecithin cholesterol acyltransferase gene in a Chilean patient with hypoalphalipoproteinemia.
    Tobar HE; Cataldo LR; González T; Rodríguez R; Serrano V; Arteaga A; Álvarez-Mercado A; Lagos CF; Vicuña L; Miranda JP; Pereira A; Bravo C; Aguilera CM; Eyheramendy S; Uauy R; Martínez Á; Gil Á; Francone O; Rigotti A; Santos JL
    Lipids Health Dis; 2019 Jun; 18(1):132. PubMed ID: 31164121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new molecular defect in the lecithin: cholesterol acyltransferase (LCAT) gene associated with fish eye disease.
    Contacos C; Sullivan DR; Rye KA; Funke H; Assmann G
    J Lipid Res; 1996 Jan; 37(1):35-44. PubMed ID: 8820100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The molecular basis of lecithin:cholesterol acyltransferase deficiency syndromes: a comprehensive study of molecular and biochemical findings in 13 unrelated Italian families.
    Calabresi L; Pisciotta L; Costantin A; Frigerio I; Eberini I; Alessandrini P; Arca M; Bon GB; Boscutti G; Busnach G; Frascà G; Gesualdo L; Gigante M; Lupattelli G; Montali A; Pizzolitto S; Rabbone I; Rolleri M; Ruotolo G; Sampietro T; Sessa A; Vaudo G; Cantafora A; Veglia F; Calandra S; Bertolini S; Franceschini G
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1972-8. PubMed ID: 15994445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markedly accelerated catabolism of apolipoprotein A-II (ApoA-II) and high density lipoproteins containing ApoA-II in classic lecithin: cholesterol acyltransferase deficiency and fish-eye disease.
    Rader DJ; Ikewaki K; Duverger N; Schmidt H; Pritchard H; Frohlich J; Clerc M; Dumon MF; Fairwell T; Zech L
    J Clin Invest; 1994 Jan; 93(1):321-30. PubMed ID: 8282802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A frameshift mutation in the human apolipoprotein A-I gene causes high density lipoprotein deficiency, partial lecithin: cholesterol-acyltransferase deficiency, and corneal opacities.
    Funke H; von Eckardstein A; Pritchard PH; Karas M; Albers JJ; Assmann G
    J Clin Invest; 1991 Jan; 87(1):371-6. PubMed ID: 1898657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion).
    Wada M; Iso T; Asztalos BF; Takama N; Nakajima T; Seta Y; Kaneko K; Taniguchi Y; Kobayashi H; Nakajima K; Schaefer EJ; Kurabayashi M
    Atherosclerosis; 2009 Nov; 207(1):157-61. PubMed ID: 19473658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of antioxidant/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders.
    Daniil G; Phedonos AA; Holleboom AG; Motazacker MM; Argyri L; Kuivenhoven JA; Chroni A
    Clin Chim Acta; 2011 Jun; 412(13-14):1213-20. PubMed ID: 21420943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homozygous lecithin:cholesterol acyltransferase (LCAT) deficiency due to a new loss of function mutation and review of the literature.
    Roshan B; Ganda OP; Desilva R; Ganim RB; Ward E; Haessler SD; Polisecki EY; Asztalos BF; Schaefer EJ
    J Clin Lipidol; 2011; 5(6):493-9. PubMed ID: 22108153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two different allelic mutations in the lecithin-cholesterol acyltransferase gene associated with the fish eye syndrome. Lecithin-cholesterol acyltransferase (Thr123----Ile) and lecithin-cholesterol acyltransferase (Thr347----Met).
    Klein HG; Lohse P; Pritchard PH; Bojanovski D; Schmidt H; Brewer HB
    J Clin Invest; 1992 Feb; 89(2):499-506. PubMed ID: 1737840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review on lecithin:cholesterol acyltransferase deficiency.
    Saeedi R; Li M; Frohlich J
    Clin Biochem; 2015 May; 48(7-8):472-5. PubMed ID: 25172171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea.
    Flores R; Jin X; Chang J; Zhang C; Cogan DG; Schaefer EJ; Kruth HS
    Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31779197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of the murine lecithin:cholesterol acyltransferase gene causes impairment of adrenal lipid delivery and up-regulation of scavenger receptor class B type I.
    Ng DS; Francone OL; Forte TM; Zhang J; Haghpassand M; Rubin EM
    J Biol Chem; 1997 Jun; 272(25):15777-81. PubMed ID: 9188474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese family with a deficiency of lecithin:cholesterol acyltransferase (LCAT).
    Naito M; Maeda E; Yoshino G; Kasuga M; Iguchi A; Kuzuya F
    Intern Med; 1994 Nov; 33(11):677-82. PubMed ID: 7849380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of mutations in LCAT in patients with low HDL cholesterol levels in The Netherlands: identification and characterization of eight novel mutations.
    Holleboom AG; Kuivenhoven JA; Peelman F; Schimmel AW; Peter J; Defesche JC; Kastelein JJ; Hovingh GK; Stroes ES; Motazacker MM
    Hum Mutat; 2011 Nov; 32(11):1290-8. PubMed ID: 21901787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Inborn errors of high-density lipoprotein metabolism].
    von Eckardstein A
    Internist (Berl); 2019 Dec; 60(12):1311-1318. PubMed ID: 31686116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial lecithin:cholesterol acyltransferase deficiency: molecular analysis of a compound heterozygote: LCAT (Arg147 --> Trp) and LCAT (Tyr171 --> Stop).
    Guerin M; Dachet C; Goulinet S; Chevet D; Dolphin PJ; Chapman MJ; Rouis M
    Atherosclerosis; 1997 May; 131(1):85-95. PubMed ID: 9180249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.